Guided Therapy Systems Keeps Options Open On Tissue Regen Device
Executive Summary
Guided Therapy Systems CEO Michael Slayton, PhD, has a history of breaking innovative medical technology, with a primary focus on diagnostic and therapeutic ultrasound applications. He tells In Vivo about the 22-year engineering journey that has led him and the company he founded to the cusp of market launch of a non-invasive tissue regeneration device for musculoskeletal injuries.
You may also be interested in...
Going More Than Skin Deep Into Merz’s Ulthera Acquisition
New Enterprise Associates registered one of its biggest returns ever when Merz agreed to pay up to $600 million for aesthetics company Ulthera. CEO Matthew Likens and lead investor Justin Klein, MD, discuss specifics about the blockbuster deal.
Post-Brexit MHRA Will Embrace Medtech ‘Innovation Pull’ In The UK
The national regulator is to undergo a review in 2021 as the UK begins life as a former EU member, presenting opportunities to be seized.
Advancing The Precision Mission At RSNA 2020
RSNA is the next major global medtech event to be run under a virtual format this fall. Under COVID-19, the major medtechs are finding different ways to demonstrate value, as Royal Philips explains.
Need a specific report? 1000+ reports available
Buy Reports